CFTR and chronic obstructive pulmonary disease: We demonstrate here that HDACi by SAHA can not only correct ΔF508-CFTR proteostasis defect and/or function but also control pathogenesis of chronic obstructive lung disease by directly targeting IL-8-mediated neutrophil- chemotaxis and augmenting T-regs.